Validation system draws varying reactions

Published: 2008-04-23 06:59:00

Updated: 2008-04-23 06:59:00

The majority of small- and medium-sized pharmaceutical companies have called for the government to delay the controversial validation system under the current Good Clinical Practice (cGMP) due to heavier financial burden associated with quality control testing, control system, and additional faci...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK